These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 22614045

  • 1. Identification of a new protein biomarker for colorectal cancer diagnosis.
    Zhai XH, Yu JK, Yang FQ, Zheng S.
    Mol Med Rep; 2012 Aug; 6(2):444-8. PubMed ID: 22614045
    [Abstract] [Full Text] [Related]

  • 2. Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach.
    Yu J, Zhai X, Li X, Zhong C, Guo C, Yang F, Yuan Y, Zheng S.
    Sci Rep; 2017 Oct 27; 7(1):14265. PubMed ID: 29079854
    [Abstract] [Full Text] [Related]

  • 3. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.
    Xu W, Hu Y, Li J, He X, Fu Z, Pan T, Liu H, He H, Ge W, Yu J, Wei Q, Zheng S, Chen Y, Zhang S.
    Discov Med; 2015 Oct 27; 20(110):239-53. PubMed ID: 26562477
    [Abstract] [Full Text] [Related]

  • 4. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer.
    Liu C, Pan C, Shen J, Wang H, Yong L.
    Int J Med Sci; 2011 Jan 03; 8(1):39-47. PubMed ID: 21234268
    [Abstract] [Full Text] [Related]

  • 5. Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry.
    Deng BG, Yao JH, Liu QY, Feng XJ, Liu D, Zhao L, Tu B, Yang F.
    Asian Pac J Cancer Prev; 2013 Jan 03; 14(10):6069-75. PubMed ID: 24289627
    [Abstract] [Full Text] [Related]

  • 6. Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.
    Helgason HH, Engwegen JY, Zapatka M, Vincent A, Cats A, Boot H, Beijnen JH, Schellens JH.
    Oncol Rep; 2010 Jul 03; 24(1):57-64. PubMed ID: 20514444
    [Abstract] [Full Text] [Related]

  • 7. Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer.
    Wang Q, Shen J, Li ZF, Jie JZ, Wang WY, Wang J, Zhang ZT, Li ZX, Yan L, Gu J.
    BMC Cancer; 2009 Aug 19; 9():287. PubMed ID: 19689818
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
    Engwegen JY, Helgason HH, Cats A, Harris N, Bonfrer JM, Schellens JH, Beijnen JH.
    World J Gastroenterol; 2006 Mar 14; 12(10):1536-44. PubMed ID: 16570345
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer.
    Bhardwaj M, Terzer T, Schrotz-King P, Brenner H.
    Int J Mol Sci; 2021 Jan 26; 22(3):. PubMed ID: 33530402
    [Abstract] [Full Text] [Related]

  • 12. Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancer.
    Albrethsen J, Bøgebo R, Møller CH, Olsen JA, Raskov HH, Gammeltoft S.
    Proteomics Clin Appl; 2012 Apr 26; 6(3-4):182-9. PubMed ID: 22532454
    [Abstract] [Full Text] [Related]

  • 13. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
    Xu WH, Chen YD, Hu Y, Yu JK, Wu XG, Jiang TJ, Zheng S, Zhang SZ.
    J Zhejiang Univ Sci B; 2006 Mar 26; 7(3):235-40. PubMed ID: 16502512
    [Abstract] [Full Text] [Related]

  • 14. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP, Shen J, Li ZF, Yan L, Gu J.
    Cancer Invest; 2006 Dec 26; 24(8):747-53. PubMed ID: 17162557
    [Abstract] [Full Text] [Related]

  • 15. Case-controlled identification of colorectal cancer based on proteomic profiles and the potential for screening.
    Huijbers A, Mesker WE, Mertens BJ, Bladergroen MR, Deelder AM, van der Burgt YE, Tollenaar RA.
    Colorectal Dis; 2014 Nov 26; 16(11):907-13. PubMed ID: 25243779
    [Abstract] [Full Text] [Related]

  • 16. Detection and identification of potential biomarkers of breast cancer.
    Fan Y, Wang J, Yang Y, Liu Q, Fan Y, Yu J, Zheng S, Li M, Wang J.
    J Cancer Res Clin Oncol; 2010 Aug 26; 136(8):1243-54. PubMed ID: 20237941
    [Abstract] [Full Text] [Related]

  • 17. Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer.
    Fan NJ, Kang R, Ge XY, Li M, Liu Y, Chen HM, Gao CF.
    Diagn Pathol; 2014 Mar 12; 9():53. PubMed ID: 24618180
    [Abstract] [Full Text] [Related]

  • 18. Histone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients.
    Duan B, Bai J, Qiu J, Wang J, Tong C, Wang X, Miao J, Li Z, Li W, Yang J, Huang C.
    EBioMedicine; 2018 Nov 12; 37():134-143. PubMed ID: 30361067
    [Abstract] [Full Text] [Related]

  • 19. Low-mass-ion discriminant equation: a new concept for colorectal cancer screening.
    Lee JH, Kim KH, Park JW, Chang HJ, Kim BC, Kim SY, Kim KG, Lee ES, Kim DY, Oh JH, Yoo BC, Kim IH.
    Int J Cancer; 2014 Apr 15; 134(8):1844-53. PubMed ID: 24096867
    [Abstract] [Full Text] [Related]

  • 20. Metabonomics identifies serum metabolite markers of colorectal cancer.
    Tan B, Qiu Y, Zou X, Chen T, Xie G, Cheng Y, Dong T, Zhao L, Feng B, Hu X, Xu LX, Zhao A, Zhang M, Cai G, Cai S, Zhou Z, Zheng M, Zhang Y, Jia W.
    J Proteome Res; 2013 Jun 07; 12(6):3000-9. PubMed ID: 23675754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.